Terms: = Head and neck cancer AND Ki-67 AND Staging
52 results:
1. Efficacy of concurrent chemoradiotherapy combined with nimotuzumab in the treatment of nasopharyngeal carcinoma with cervical lymph node metastasis.
Lu J; Wei J; Xiao X; Wei Y; Li M; Huang Y; Deng W; Wang H; Gui Z; Liu F; Jiang H; Zhang J; Weng J; Qu S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2479-2488. PubMed ID: 36577788
[TBL] [Abstract] [Full Text] [Related]
2. Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/ERK signaling pathway.
Weng K; Li L; Zhou H
Histol Histopathol; 2023 Dec; 38(12):1381-1390. PubMed ID: 36537752
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Utility of the ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center.
Hellgren LS; Stenman A; Paulsson JO; Höög A; Larsson C; Zedenius J; Juhlin CC
Endocr Pathol; 2022 Jun; 33(2):231-242. PubMed ID: 35305239
[TBL] [Abstract] [Full Text] [Related]
4. Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):253-259. PubMed ID: 35092395
[TBL] [Abstract] [Full Text] [Related]
5. Diffuse pattern, orbital invasion, perineural invasion and ki-67 are associated with nodal metastasis in patients with eyelid sebaceous carcinoma.
Gu X; Xie M; Luo Y; Song X; Xu S; Fan X
Br J Ophthalmol; 2023 Jun; 107(6):756-762. PubMed ID: 35063931
[TBL] [Abstract] [Full Text] [Related]
6. Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma.
Gadbail AR; Sarode SC; Chaudhary MS; Gondivkar SM; Tekade SA; Yuwanati M; Patil S
J Appl Oral Sci; 2021; 29():e20200751. PubMed ID: 33656066
[TBL] [Abstract] [Full Text] [Related]
7. ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.
Viana AOR; Gonçalves Filho J; Francisco ALN; Pinto CAL; Kowalski LP
Acta Otorhinolaryngol Ital; 2020 Jun; 40(3):190-197. PubMed ID: 32773780
[TBL] [Abstract] [Full Text] [Related]
8. [Expression and significance of ki-67, PI3K and Beclin1 in oral squamous cell carcinoma].
DA Y; Yang Z; Xia MM; Wang MJ
Shanghai Kou Qiang Yi Xue; 2020 Feb; 29(1):75-79. PubMed ID: 32524126
[TBL] [Abstract] [Full Text] [Related]
9. [Misdiagnosis analysis: 120 patients with nasal extranodal NK/T cell lymphoma in head and neck].
Liu PL; Cheng ZX; Lu MP; Zhang LQ; Chen HB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 34(1):73-78. PubMed ID: 32086904
[No Abstract] [Full Text] [Related]
10. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma.
Lim CH; Park YJ; Shin M; Cho YS; Choi JY; Lee KH; Hyun SH
Clin Nucl Med; 2020 Mar; 45(3):e128-e133. PubMed ID: 31977480
[TBL] [Abstract] [Full Text] [Related]
11. [Prognosis factors analysis of 56 cases of non-Hodgkin's lymphoma originating from the nasopharynx].
Li SD; Ba YP; Zhang PW
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):651-653. PubMed ID: 31327206
[No Abstract] [Full Text] [Related]
12. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
[TBL] [Abstract] [Full Text] [Related]
13. The correlation of prognostic biomarkers (ki-67, Bcl-2, HIF-1α, cyclin D1) with metabolic tumor volume measured by F-FDG PET/CT inlaryngeal cancer.
Eryilmaz A; Cengiz A; Basal Y; Meteoglu I; Omurlu IK; Yurekli Y
J Cancer Res Ther; 2018; 14(5):994-998. PubMed ID: 30197337
[TBL] [Abstract] [Full Text] [Related]
14. Associations Between [
Surov A; Meyer HJ; Höhn AK; Winter K; Sabri O; Purz S
Mol Imaging Biol; 2019 Apr; 21(2):368-374. PubMed ID: 29931433
[TBL] [Abstract] [Full Text] [Related]
15. Sclerosing microcystic adenocarcinoma of the tongue: a report of 2 further cases and review of the literature.
Wood A; Conn BI
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Apr; 125(4):e94-e102. PubMed ID: 29398516
[TBL] [Abstract] [Full Text] [Related]
16. Adenoid Cystic Carcinoma of the Oral Cavity: Radiology-Pathology Correlation.
Uraizee I; Cipriani NA; Ginat DT
Head Neck Pathol; 2018 Dec; 12(4):562-566. PubMed ID: 28879643
[TBL] [Abstract] [Full Text] [Related]
17. Cell proliferation markers at the invasive tumor front of oral squamous cell carcinoma: comparative analysis in relation to clinicopathological parameters of patients.
Cortegoso AVB; Laureano NK; Silva ADD; Danilevicz CK; Magnusson AS; Visioli F; Rados PV
J Appl Oral Sci; 2017; 25(3):318-323. PubMed ID: 28678951
[TBL] [Abstract] [Full Text] [Related]
18. Neuroendocrine Tumors of the Esophagus: State of the Art in Diagnostic and Therapeutic Management.
Schizas D; Mastoraki A; Kirkilesis GI; Sioulas AD; Papanikolaou IS; Misiakos EP; Arkadopoulos N; Liakakos T
J Gastrointest Cancer; 2017 Dec; 48(4):299-304. PubMed ID: 28656561
[TBL] [Abstract] [Full Text] [Related]
19. Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma.
Lian YF; Yuan J; Cui Q; Feng QS; Xu M; Bei JX; Zeng YX; Feng L
PLoS One; 2016; 11(3):e0152820. PubMed ID: 27030985
[TBL] [Abstract] [Full Text] [Related]
20. Medullary thyroid carcinoma - PET/CT imaging with 68Ga-labelled gastrin and somatostatin analogues.
Kunikowska J; Ziemnicka K; Pawlak D; Ruchała M; Kolasa A; Janicka-Jedyńska M; Woźniak A; Mikołajczak R; Królicki L
Endokrynol Pol; 2016; 67(1):68-71. PubMed ID: 26884118
[TBL] [Abstract] [Full Text] [Related]
[Next]
